Market Place
Sourcing Support
All News #Library
Biotech
XOMA Royalty to Acquire LAVA Therapeutics for Up to $1.24 Cash
04 Aug 2025 //
GLOBENEWSWIRE
LAVA Reports Q1 2025 Financials, Provides Business Update
14 May 2025 //
GLOBENEWSWIRE
LAVA Reports Q4 2024 Financial Results and Business Update
28 Mar 2025 //
GLOBENEWSWIRE
LAVA Announces Evaluation of Strategic Options
25 Feb 2025 //
GLOBENEWSWIRE
LAVA Reports Q3 2024 Financial Results
10 Dec 2024 //
GLOBENEWSWIRE
Lava burnt by failure clinical-stage cancer drug in phase 1
10 Dec 2024 //
FIERCE BIOTECH
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
21 May 2024 //
GLOBENEWSWIRE
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052
05 Mar 2024 //
GLOBENEWSWIRE
LAVA Announces Initial Data from Ongoing Phase 1/2a Clinical Trial of LAVA-1207
16 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.